introduct
respiratori
syncyti
viru
rsv
associ
substanti
morbid
mortal
sinc
predomin
viral
agent
caus
respiratori
tract
infect
infant
young
children
elderli
consid
avail
rsv
vaccin
come
year
molecular
understand
rsv
necessari
object
object
present
studi
describ
rsv
epidemiolog
genotyp
variabl
portug
period
materi
method
epidemiolog
data
rsvposit
sampl
patient
respiratori
infect
collect
nonsentinel
sentinel
influenza
surveil
system
iss
rsv
detect
subtyp
b
sequenc
second
hypervari
region
g
gene
perform
molecular
method
phylogenet
tree
gener
use
neighborjoin
method
pdistanc
model
mega
result
rsv
preval
vari
sentinel
nonsentinel
iss
higher
p
among
children
age
year
bronchiol
influenzalik
ill
associ
p
rsv
laboratori
confirm
among
children
age
month
adult
year
respect
sequenc
sampl
rsva
rsvb
strain
cluster
mainli
genotyp
respect
although
also
present
conclus
sequenc
phylogenet
analysi
reflect
rel
high
divers
portugues
rsv
strain
genotyp
circul
portug
sinc
respect
predomin
whole
studi
period
respiratori
syncyti
viru
rsv
rsvb
antigen
differ
often
cocircul
although
one
usual
predomin
genet
divers
increas
spread
new
genotyp
among
subtyp
last
year
second
hypervari
region
carri
cterminu
g
attach
glycoprotein
high
degre
diverg
therebi
use
main
indic
studi
rsv
evolut
date
base
region
rsva
rsvb
genotyp
describ
rsv
associ
substanti
morbid
mortal
sinc
major
caus
lower
respiratori
tract
infect
lrti
childhood
result
hospit
due
sever
infect
mani
case
moreov
caus
sever
respiratori
tract
infect
adult
especi
elderli
immunosuppress
patient
symptomat
support
care
palivizumab
current
avail
option
rsv
diseas
clinic
manag
reduc
symptom
sever
decreas
hospit
rate
mortal
fortun
rsv
vaccin
progress
phase
iii
clinic
trial
could
avail
come
year
g
protein
suggest
plausibl
target
therefor
ongo
global
surveil
character
circul
rsv
strain
requir
evidencebas
vaccin
polici
portug
rsv
case
detect
sinc
nation
influenza
surveil
system
iss
influenza
season
week
septemb
week
june
next
year
studi
aim
describ
preval
genet
variabl
rsv
period
portug
well
evalu
associ
subtyp
age
clinic
diagnos
among
patient
laboratoryconfirm
rsv
infect
portugues
iss
account
sentinel
nonsentinel
compon
sentinel
iss
made
gener
practition
gp
sentinel
network
gp
euroeva
portugues
compon
imov
project
emergencyobstetr
depart
network
hospit
nonsentinel
iss
integr
portugues
laboratori
network
diagnosi
influenza
infect
plndii
compris
hospitalbas
laboratori
coordin
nation
institut
health
doutor
ricardo
jorg
insa
network
integr
gener
hospit
pediatr
adult
emerg
room
medic
ward
one
refer
pediatr
hospit
lisbon
iss
weekli
report
laboratori
data
test
sampl
european
influenza
surveil
network
coordin
european
centr
diseas
prevent
control
ecdc
whoeurop
demograph
clinic
laboratori
data
rsvposit
case
collect
iss
rsvposit
respiratori
sampl
collect
three
popul
age
influenzalik
ill
ili
patient
report
sentinel
iss
period
ii
children
age
year
respiratori
infect
diagnos
plndii
period
iii
adult
year
respiratori
infect
diagnos
plndii
season
sampl
includ
nasopharyng
oropharyng
swab
nasopharyng
aspir
lavag
studi
approv
health
ethic
committe
insa
viral
nucleic
acid
extract
perform
use
autom
acid
extract
platform
easymag
molecular
detect
rsv
identif
subtyp
b
perform
use
realtim
pcr
adapt
previou
protocol
describ
gunson
et
al
genotyp
sequenc
rsvposit
iss
case
prospect
perform
sinc
season
retrospect
carri
time
addit
plndii
voluntarili
select
first
two
rsv
posit
sampl
per
week
children
age
year
adult
age
year
convent
pcr
sequenc
analysi
perform
onestep
rtpcr
adapt
previous
publish
protocol
firstround
pcr
ggcaatgataatctcaac
gtt
atg
aca
ctg
gta
tac
caa
cc
use
wherea
second
round
pcr
sequenc
gat
gattaccattttgaagtgttca
caactccattgttatt
tgcc
select
size
product
around
pb
potenti
nglycosyl
site
asnxserthr
identifi
netnglyc
server
http
wwwcbsdtudkservicesnetnglyc
align
perform
muscl
method
phylogenet
tree
gener
use
neighborjoin
method
pdistanc
model
bootstrap
resampl
replic
mega
addit
worldwid
refer
strain
rsva
rsvb
retriev
genbank
http
wwwncbinlmnihgov
genbank
rsva
strain
previou
studi
portug
use
tree
construct
togeth
sequenc
gener
studi
sequenc
homolog
nucleotid
sequenc
repres
one
strain
submit
genbank
databas
access
number
rsva
rsvb
demograph
epidemiolog
characterist
describ
use
proport
group
comparison
assess
chisquar
test
fisher
exact
test
test
pvalu
consid
statist
signific
statist
analysi
perform
use
stata
rsv
identifi
sampl
iss
week
week
fig
total
rsv
case
codetect
respiratori
virus
mainli
picornaviru
coronaviru
adenoviru
major
rsv
case
year
case
miss
age
sex
includ
studi
age
miss
five
rsvposit
rsvneg
case
sex
miss
one
rsvposit
rsvneg
case
observ
frequenc
higher
expect
among
year
age
group
p
demograph
characterist
rsvposit
neg
case
describ
tabl
rsvposit
frequenc
significantli
p
higher
among
children
age
year
one
expect
associ
age
rsv
infect
sequenc
determin
rsvposit
sampl
period
demograph
clinic
characterist
patient
includ
sentinel
iss
tabl
plndii
tabl
describ
associ
rsv
subtyp
assess
rsv
case
detect
iss
observ
rsvb
subtyp
frequenc
significantli
higher
femal
p
year
age
group
p
sampl
rsv
case
detect
plndii
belong
mostli
children
age
month
present
rsva
frequenc
significantli
p
higher
one
expect
three
hundr
thirtysix
case
hospit
patient
bronchiol
children
age
month
ili
adult
age
year
found
significantli
p
associ
rsv
laboratori
confirm
moreov
observ
frequenc
rsvposit
ili
pneumonia
among
children
month
year
old
also
significantli
p
higher
one
expect
therefor
diagnost
associ
laboratoryconfirm
rsv
infect
among
age
group
addit
sampl
studi
period
rsva
strain
period
includ
phylogenet
analysi
fig
rsvb
strain
cluster
two
bueno
air
genotyp
latter
present
season
fig
strain
align
refer
strain
wherea
strain
compar
refer
strain
supplementari
fig
eight
strain
show
least
one
differ
nucleotid
highest
number
amino
acid
substitut
found
genotyp
k
p
p
common
substitut
among
strain
addit
contain
g
rk
kr
substitut
comparison
strain
fact
last
substitut
led
loss
one
potenti
nglycosyl
site
anoth
site
loss
due
substitut
strain
except
one
strain
howev
addit
two
conserv
nglycosyl
site
two
novel
site
due
n
n
substitut
observ
one
two
strain
respect
rsv
b
strain
analyz
comparison
first
report
ba
strain
belong
genotyp
supplementari
fig
total
rsvb
group
strain
includ
six
strain
differ
amino
acid
combin
observ
substitut
p
p
identifi
rsvb
virus
strain
show
amino
acid
sequenc
substitut
g
exclus
genotyp
three
conserv
site
identifi
amino
acid
although
strain
lost
due
differ
substitut
howev
two
addit
site
amino
acid
substitut
n
n
identifi
specif
rsvb
strain
circul
portugues
rsv
strain
sentinel
nonsentinel
iss
character
epidemiolog
genet
term
order
provid
better
understand
molecular
epidemiolog
rsv
infect
countri
rsv
detect
rate
sentinel
iss
similar
frequenc
report
outpati
brazil
korea
china
although
lower
european
countri
plndii
rsv
preval
higher
one
found
sentinel
iss
sinc
network
compos
hospitalbas
laboratori
collect
data
inpati
sentinel
iss
use
european
union
eu
ili
case
definit
accur
rsv
detect
portug
remark
number
test
sampl
season
could
explain
consciousnessrais
relev
rsv
diseas
among
physician
therefor
point
view
preval
season
might
best
repres
countri
similar
find
seneg
thailand
spain
differ
region
india
nonetheless
true
comparison
rsv
preval
differ
geograph
area
difficult
perform
take
account
differ
studi
design
even
studi
preval
widerang
accord
season
bronchiol
pneumonia
significantli
associ
rsvposit
case
among
children
age
year
consist
previou
studi
found
rsv
major
caus
acut
lrti
age
group
rsva
rsvb
subtyp
cocircul
portug
rsva
subtyp
preval
season
wherea
rsvb
subtyp
domin
next
two
consecut
season
period
shift
year
rsv
subtyp
report
world
rsva
subtyp
significantli
higher
children
younger
year
especi
age
month
may
concern
sinc
rsva
infect
associ
sever
bronchiol
higher
diseas
sever
score
howev
discrep
describ
inde
specif
substitut
may
indic
virul
strain
specif
period
time
better
subtyp
rsvb
subtyp
significantli
higher
year
old
femal
patient
howev
fact
could
explain
due
low
number
character
case
sentinel
iss
rsva
strain
cluster
genotyp
consist
sever
studi
report
almost
exclus
genotyp
genotyp
detect
season
howev
fact
genotyp
found
two
period
might
due
sequenc
bia
portug
genotyp
detect
season
first
time
sinc
predomin
countri
report
worldwid
regard
rsvb
genet
divers
belong
ba
genotyp
alreadi
detect
least
countri
genotyp
predomin
portug
sinc
countri
detect
alongsid
genotyp
remain
genotyp
detect
onward
sinc
new
genotyp
ad
time
differ
author
follow
propos
criteria
venter
et
al
howev
addit
new
sequenc
differ
locat
recent
epidem
led
reclassifi
previou
sequenc
exist
genotyp
even
consolid
new
one
present
studi
consid
rsva
strain
belong
genotyp
sinc
mostli
identifi
cluster
show
bootstrap
valu
insert
characterist
variant
therefor
standard
criteria
may
play
key
role
assign
adequ
genotyp
assur
compar
differ
studi
regardless
addit
new
sequenc
align
predict
amino
acid
sequenc
strain
genotyp
confirm
rel
high
genet
variabl
associ
strain
subtyp
show
common
chang
conserv
nglycosil
site
subtitut
lead
loss
gain
site
previous
report
within
rsva
strain
number
substitut
among
strain
higher
compar
counterpart
strain
show
homolog
refer
strain
thailand
exclus
substitut
g
observ
studi
continu
surveil
amino
acid
chang
well
novel
nlink
glycosyl
site
perform
sinc
alter
antigen
characterist
viral
surfac
glycoprotein
may
enabl
immun
evas
lead
evolutionari
advantag
fact
spread
ba
genotyp
explain
duplic
associ
increas
viru
attach
fit
main
limit
studi
restrospect
perform
season
consequ
low
number
success
sequenc
rsv
sampl
time
sentinel
iss
due
insuffici
viral
load
rna
degrad
conserv
howev
studi
advantag
includ
larg
sampl
size
differ
region
four
consecut
season
portug
therebi
provid
use
inform
rsv
epidemiolog
genotyp
variabl
countri
recent
period
conclus
studi
first
explor
rsv
epidemiolog
genotyp
variabl
portug
constitut
contribut
rsv
knowledg
evolut
strain
circul
necessari
rsv
vaccin
develop
futur
monitor
vaccin
effect
continu
surveil
specif
genom
chang
standard
criteria
optim
genotyp
assign
would
relev
regard
vaccin
design
rsv
surveil
includ
viru
character
research
receiv
specif
grant
fund
agenc
public
commerci
notforprofit
sector
ethic
approv
studi
approv
health
ethic
committe
insa
none
